Edwards Lifesciences Corporatio
EW
Jodie read · what matters now
Revenue increased 16.7% versus the comparable filing period.
The story is only the start. Jodie keeps watching the filing evidence, the companies connected to EW, and whether its market group begins moving.
Latest filing assessment · baseline
The latest filing presents a mixed picture
10-Q filed 2026-05-06 against the comparable filing from 2025-05-06.
What improved
- Revenue increased 16.7% versus the comparable filing period.
- Operating margin improved 1.0 percentage points.
What weakened
- Gross margin fell 0.6 percentage points.
- Net margin fell 2.2 percentage points.
- Operating cash flow covered only 0.12x net income.
Filing receipts
“Gross profit as a percentage of net sales decreased for the three months ended March 31, 2026, primarily driven by a 0.3 percentage point negative impact from foreign currency rate fluctuations, including the settlement of foreign currency hedging contracts, and additional manufacturing expenses related to expansion of new therapies.”
“In addition, during the three months ended March 31, 2026, foreign currency exchange rate fluctuations increased net sales outside of the United States by $32.0 million, primarily due to the strengthening of the Euro against the United States dollar.”
“Gross profit as a percentage of sales decreased primarily due to the impact from foreign currency rate fluctuations and additional manufacturing expenses related to expansion of new therapies.”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Who this business touches
The relationships behind EW
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
Filing peers
Companies whose filings use similar operating language.
You can see the shape of the network here. Pro opens 13 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →
What is moving around it
Live connections
EW is currently a Early Follower in the organic co-movement group Healthcare Investment Firms. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Theme membership history
No durable theme membership has been observed for this name yet.